Centogene Research Development vs Reconciled Depreciation Analysis

CNTG Stock

USD 0.10 0.02 12.92%

Centogene financial indicator trend analysis is way more than just evaluating Centogene B V prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Centogene B V is a good investment. Please check the relationship between Centogene Research Development and its Reconciled Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Centogene B V Research Development account and Reconciled Depreciation. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Centogene's Research Development and Reconciled Depreciation is 0.94. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Centogene B V, assuming nothing else is changed. The correlation between historical values of Centogene's Research Development and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Centogene B V are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Research Development i.e., Centogene's Research Development and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Reconciled Depreciation

Most indicators from Centogene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Centogene B V current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

At this time, Centogene's Tax Provision is most likely to increase significantly in the upcoming years. The Centogene's current Enterprise Value is estimated to increase to about 173.6 M, while Discontinued Operations is projected to decrease to roughly 4.3 M.

	2021	2022	2023	2024 (projected)
Interest Expense	851K	3.6M	8.2M	8.6M
Depreciation And Amortization	20.8M	10.2M	7.5M	9.6M

Interest Expense Depreciation And Amortization

Centogene fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Short Long Term Debt
Total Assets		0.53	-0.14	0.77	0.6	0.72	0.84	0.67	0.12	-0.58	0.74	0.96	0.83	0.63	0.54	0.37	0.96	0.95	0.23	0.84	0.69	0.83	0.95	0.48	0.8	-0.26
Short Long Term Debt Total	0.53		-0.59	0.46	-0.34	0.59	0.04	0.0	0.89	-0.95	0.1	0.57	0.19	0.48	0.84	0.84	0.57	0.59	0.8	0.64	0.86	0.29	0.37	0.92	0.83	0.54
Other Current Liab	-0.14	-0.59		0.09	0.25	-0.67	0.07	-0.18	-0.65	0.4	0.32	-0.16	-0.22	-0.44	-0.23	-0.37	-0.16	-0.09	-0.38	-0.15	-0.55	0.18	0.08	-0.65	-0.34	-0.42
Total Current Liabilities	0.77	0.46	0.09		0.31	0.43	0.61	0.37	0.18	-0.58	0.84	0.69	0.54	0.32	0.59	0.35	0.69	0.86	0.38	0.68	0.47	0.92	0.7	0.23	0.75	0.05
Total Stockholder Equity	0.6	-0.34	0.25	0.31		0.32	0.9	0.78	-0.68	0.26	0.6	0.53	0.79	0.3	-0.22	-0.38	0.53	0.46	-0.52	0.34	0.03	0.54	0.66	-0.25	0.1	-0.82
Other Liab	0.72	0.59	-0.67	0.43	0.32		0.58	0.76	0.42	-0.52	0.26	0.61	0.82	0.88	0.32	0.43	0.61	0.68	0.25	0.62	0.7	0.42	0.59	0.62	0.63	0.0
Net Tangible Assets	0.84	0.04	0.07	0.61	0.9	0.58		0.84	-0.35	-0.08	0.73	0.76	0.92	0.49	0.09	-0.12	0.76	0.73	-0.27	0.59	0.3	0.74	0.82	0.07	0.42	-0.54
Property Plant And Equipment Net	0.67	0.0	-0.18	0.37	0.78	0.76	0.84		-0.23	0.03	0.52	0.51	0.95	0.74	-0.19	-0.12	0.51	0.54	-0.28	0.39	0.25	0.55	0.68	0.04	0.27	-0.5
Net Debt	0.12	0.89	-0.65	0.18	-0.68	0.42	-0.35	-0.23		-0.81	-0.25	0.13	-0.12	0.35	0.67	0.82	0.13	0.24	0.79	0.32	0.62	-0.07	-0.04	0.8	0.55	0.77
Retained Earnings	-0.58	-0.95	0.4	-0.58	0.26	-0.52	-0.08	0.03	-0.81		-0.2	-0.6	-0.19	-0.45	-0.93	-0.93	-0.6	-0.71	-0.85	-0.75	-0.86	-0.39	-0.46	-0.83	-0.89	-0.4
Accounts Payable	0.74	0.1	0.32	0.84	0.6	0.26	0.73	0.52	-0.25	-0.2		0.66	0.58	0.18	0.25	-0.03	0.66	0.7	0.01	0.42	0.18	0.97	0.78	-0.12	0.47	-0.29
Cash	0.96	0.57	-0.16	0.69	0.53	0.61	0.76	0.51	0.13	-0.6	0.66		0.71	0.5	0.59	0.37	1.0	0.88	0.29	0.84	0.75	0.75	0.89	0.56	0.83	-0.24
Non Current Assets Total	0.83	0.19	-0.22	0.54	0.79	0.82	0.92	0.95	-0.12	-0.19	0.58	0.71		0.76	0.07	0.05	0.71	0.74	-0.12	0.63	0.46	0.66	0.79	0.23	0.5	-0.45
Non Currrent Assets Other	0.63	0.48	-0.44	0.32	0.3	0.88	0.49	0.74	0.35	-0.45	0.18	0.5	0.76		0.17	0.46	0.5	0.62	0.25	0.64	0.66	0.35	0.6	0.53	0.56	-0.17
Other Assets	0.54	0.84	-0.23	0.59	-0.22	0.32	0.09	-0.19	0.67	-0.93	0.25	0.59	0.07	0.17		0.84	0.59	0.67	0.74	0.68	0.72	0.4	0.42	0.72	0.8	0.38
Long Term Debt	0.37	0.84	-0.37	0.35	-0.38	0.43	-0.12	-0.12	0.82	-0.93	-0.03	0.37	0.05	0.46	0.84		0.37	0.56	0.85	0.63	0.77	0.17	0.31	0.75	0.72	0.35
Cash And Short Term Investments	0.96	0.57	-0.16	0.69	0.53	0.61	0.76	0.51	0.13	-0.6	0.66	1.0	0.71	0.5	0.59	0.37		0.88	0.29	0.84	0.75	0.75	0.89	0.56	0.83	-0.24
Net Receivables	0.95	0.59	-0.09	0.86	0.46	0.68	0.73	0.54	0.24	-0.71	0.7	0.88	0.74	0.62	0.67	0.56	0.88		0.4	0.91	0.73	0.83	0.89	0.49	0.87	-0.17
Common Stock Shares Outstanding	0.23	0.8	-0.38	0.38	-0.52	0.25	-0.27	-0.28	0.79	-0.85	0.01	0.29	-0.12	0.25	0.74	0.85	0.29	0.4		0.52	0.74	0.2	0.13	0.62	0.74	0.46
Long Term Debt Total	0.84	0.64	-0.15	0.68	0.34	0.62	0.59	0.39	0.32	-0.75	0.42	0.84	0.63	0.64	0.68	0.63	0.84	0.91	0.52		0.86	0.6	0.76	0.63	0.91	-0.18
Non Current Liabilities Total	0.69	0.86	-0.55	0.47	0.03	0.7	0.3	0.25	0.62	-0.86	0.18	0.75	0.46	0.66	0.72	0.77	0.75	0.73	0.74	0.86		0.39	0.57	0.85	0.93	0.08
Inventory	0.83	0.29	0.18	0.92	0.54	0.42	0.74	0.55	-0.07	-0.39	0.97	0.75	0.66	0.35	0.4	0.17	0.75	0.83	0.2	0.6	0.39		0.84	0.06	0.65	-0.23
Other Current Assets	0.95	0.37	0.08	0.7	0.66	0.59	0.82	0.68	-0.04	-0.46	0.78	0.89	0.79	0.6	0.42	0.31	0.89	0.89	0.13	0.76	0.57	0.84		0.32	0.68	-0.43
Other Stockholder Equity	0.48	0.92	-0.65	0.23	-0.25	0.62	0.07	0.04	0.8	-0.83	-0.12	0.56	0.23	0.53	0.72	0.75	0.56	0.49	0.62	0.63	0.85	0.06	0.32		0.72	0.42
Total Liab	0.8	0.83	-0.34	0.75	0.1	0.63	0.42	0.27	0.55	-0.89	0.47	0.83	0.5	0.56	0.8	0.72	0.83	0.87	0.74	0.91	0.93	0.65	0.68	0.72		0.11
Short Long Term Debt	-0.26	0.54	-0.42	0.05	-0.82	0.0	-0.54	-0.5	0.77	-0.4	-0.29	-0.24	-0.45	-0.17	0.38	0.35	-0.24	-0.17	0.46	-0.18	0.08	-0.23	-0.43	0.42	0.11

Click cells to compare fundamentals

Centogene Account Relationship Matchups

Centogene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	117.5M	150.1M	90.7M	92.8M	77.2M	95.8M
Short Long Term Debt Total	27.0M	24.1M	22.8M	60.1M	80.4M	84.4M
Other Current Liab	13.1M	20.5M	19.6M	10.1M	8.6M	10.6M
Total Current Liabilities	29M	57.1M	39.5M	24.7M	43.4M	36.5M
Total Stockholder Equity	59.9M	65.7M	27.3M	7.4M	(25.3M)	(24.0M)
Other Liab	11.2M	9.9M	9.2M	8.1M	9.3M	9.9M
Net Tangible Assets	45.7M	53.3M	18.1M	11K	12.7K	12.0K
Property Plant And Equipment Net	33.3M	38.7M	27.1M	22.2M	19.3M	23.4M
Net Debt	(9.6M)	(19.1M)	9.4M	28.1M	61.3M	64.4M
Retained Earnings	(40.6M)	(62.9M)	(109.3M)	(141.3M)	(177.4M)	(168.5M)
Accounts Payable	8.6M	31.7M	11.3M	6.3M	5.6M	11.0M
Cash	36.6M	43.2M	13.4M	32.0M	19.1M	21.7M
Non Current Assets Total	49.4M	53.1M	39.2M	33.0M	33.2M	32.4M
Non Currrent Assets Other	1.9M	2.0M	3.0M	3.4M	3.4M	4.9M
Other Assets	0.0	1.9M	2.0M	3.0M	3.4M	3.6M
Long Term Debt	12.9M	1.6M	401K	40.1M	39.9M	41.9M
Cash And Short Term Investments	36.6M	43.2M	13.4M	32.0M	19.1M	21.7M
Net Receivables	19.4M	29.2M	24.3M	16.5M	19.4M	18.4M
Common Stock Total Equity	262K	322K	2.4M	2.7M	3.1M	3.2M
Common Stock Shares Outstanding	16.4M	20.9M	22.4M	26.8M	28.2M	24.0M
Liabilities And Stockholders Equity	117.5M	150.1M	90.7M	92.8M	77.2M	90.8M
Non Current Liabilities Total	29.6M	27.2M	23.7M	60.7M	53.4M	32.7M
Capital Lease Obligations	21.7M	21.2M	19.0M	15.4M	14.6M	13.5M
Inventory	1.8M	11.4M	3.9M	1.8M	2.5M	3.3M
Other Current Assets	5.8M	8.3M	5.5M	5.5M	3.1M	5.3M
Other Stockholder Equity	106.5M	(851K)	27.5M	121.1M	139.3M	146.2M
Total Liab	58.6M	84.4M	63.2M	85.4M	96.8M	70.3M
Property Plant And Equipment Gross	33.3M	38.7M	52.0M	48.5M	50.1M	40.6M
Short Long Term Debt	3.7M	2.5M	3.8M	4.6M	25.9M	27.2M
Total Current Assets	68.1M	97.0M	51.5M	59.8M	44.1M	51.1M
Accumulated Other Comprehensive Income	98.1M	125.9M	133.9M	145.4M	148.1K	140.7K
Non Current Liabilities Other	9.9M	640K	960K	202K	48K	45.6K
Short Term Debt	7.3M	3.5M	7.1M	6.9M	28.1M	29.5M
Intangible Assets	14.1M	12.4M	9.2M	7.4M	6.9M	10.0M
Common Stock	2.4M	2.7M	2.7M	3.3M	3.5M	2.1M
Property Plant Equipment	39.1M	33.3M	38.7M	27.1M	31.1M	35.3M
Net Invested Capital	65.1M	68.6M	31.1M	52.1M	40.5M	52.5M
Net Working Capital	39.1M	39.9M	12.0M	35.2M	653K	620.4K

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:

How To Invest In Centogene

Details

Is Centogene Stock a good investment?

Details

What is Centogene's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.39)

Revenue Per Share

1.723

Quarterly Revenue Growth

(0.08)

Return On Assets

(0.27)

Return On Equity

(13.75)

The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Centogene Research Development vs Reconciled Depreciation Analysis

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Research Development

Reconciled Depreciation

Centogene fundamental ratios Correlations

Centogene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Centogene fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 0.97	Accounts Payable
Cash	+ 0.96	Total Assets
Cash And Short Term Investments	+ 0.96	Total Assets
Net Receivables	+ 0.95	Total Assets
Other Current Assets	+ 0.95	Total Assets

Retained Earnings	- 0.95	Short Long Term Debt Total
Long Term Debt	- 0.93	Retained Earnings
Other Assets	- 0.93	Retained Earnings
Total Liab	- 0.89	Retained Earnings
Non Current Liabilities Total	- 0.86	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings